How do cell-free HIV virions avoid infecting dead-end host cells and cell fragments?

AIDS Reviews

Volumn 6, Issue 3, 2004, Pages 155-160

  Iyengar, Sujatha ^a   Schwartz, David H ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Apoptosis; Chemokine receptors; HIV; Immunological synapse

Indexed keywords

ACTIN; CD4 ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN GP 120;

APOPTOSIS; CELL ACTIVATION; CELL DIVISION; CELL FUNCTION; CELL INTERACTION; CELL MEMBRANE; CELL VIABILITY; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; LYMPH NODE; NONHUMAN; PROTEIN AGGREGATION; RECEPTOR BINDING; RECEPTOR DENSITY; REVIEW; STOICHIOMETRY; TARGET CELL; UPREGULATION; VIRION; VIRUS CELL INTERACTION; VIRUS REPLICATION;

ACTINS; GENE EXPRESSION REGULATION; HIV; HIV INFECTIONS; HUMANS; RECEPTORS, HIV; VIRION;

EID: 10044296072     PISSN: 11396121     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Wyatt R, Sodroski J. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 1998;280:1884-8.
2. Gowda S, Stein B, Mohagheghpour N, et al. Evidence that T-cell activation is required for HIV-1 entry in CD4+ lymphocytes. J Immunol 1989;142:773-80.
3. Pierson T, Zhou Y, Kieffer T, et al. Molecular characterization of pre-integration latency in human immunodeficiency virus type 1 infection. J Virol 2002;76:8518-31.
4. Bleul C, Wu L, Hoxie J, et al. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci USA 1997;94:1925-30.
5. Lee B, Sharron M, Montaner L, et al. Quantification of CD4, CCR5, and CSCR4 levels on lymphocyte subsets, dendritic cells, and differennally conditioned monocyte derived macrophages. Proc Natl Acad Sci USA 1999;96:5215-20.
6. Doms R. Beyond receptor expression: the influence of receptor conformation, density, and affinity in HIV-1 infection. Virology 2000;276:229-37.
7. De Boer R, Oprea M, Antia R, et al. Recruitment times, proliferation, and apoptosis rates during the CD8(+) T-cell response to lymphocytic choriomeningitis. J Virol 2001;75:10663-9
8. Iyengar S, Chin B, Margolick J, et al. Anatomical loci of HIV-associated immune activation and association with viraemia. Lancet 2003;362:945-50.
9. Pellegrino M, Gongrong L, Potash M, et al. Contribution of multiple rounds of viral entry and reverse transcription to expression of HIV type 1. J Biol Chem 1991;266:1783-8.
10. Aupeix K, Hugel B, Martin T, et al. The significance of shed membrane particles during programmed cell death in vitro and in vivo in HIV-1 infection. J Clin Invest 1997;99:1546-54.
11. Mack M, Kleinschmidt A, Bruhl H, et al. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular HIV type 1 Infection. Nat Med 2000;6:769-75.
12. Tomiyoshi G, Horita Y, Nishita M, et al. Caspase-mediated cleavage and activation of LIM-kinase 1 and its role in apoptotic membrane blebbing. Genes Cells 2004;9:591-600.
13. Turville S, Santos J, Frank I, et al. HIV uptake, turnover, and 2-phase transfer in human dendritic cells. Blood 2004;103:2170-9.
14. Iyengar S, Hildreth J, Schwartz D. Actin-dependent receptor colocalization required for HIV entry into host cells. J Virol 1998; 72:5251-5.
15. Jolly C, Kashefi K, Hollinshead M, et al. HIV-1 cell-to-cell transfer across an ENV-induced actin-dependent synapse. J Exp Med 2004;199:283-93.
16. Pontow S, Van der Heyden N, Wei S, et al. Actin cytoskeletal reorganizations and coreceptor-mediated activation of rac during HIV-induced cell fusion. J Virol 2004;78:7138-47.
17. Kinter A, Umscheid C, Arthos J, et al. HIV envelope induces virus expression from resting CD4+ T-cells isolated from HIV-infected individuals in the absence of markers of cellular activation or apoptosis. J Immunol 2003;170:2449-55.
18. Lin C, Sewell A, Gao G, et al. Macrophage-tropic HIV induces and exploits dendritic cell chemotaxis. J Exp Med 2000;192: 587-94.
19. Kuznetsov Y, Victoria J, Robinson W, et al. Atomic force microscopy investigation of human immunodeficiency virus (HIV) and HIV-infected lymphocytes. J Virol 2003;77:11896-909.
20. Delassus S, Cheynier R, Wain-Hobson S. Non-homogeneous distribution of human immunodeficiency virus type 1 proviruses in the spleen. J Virol 1992;66:5642-5.
21. Hioe C, Bastiani L, Hildreth J, et al. Role of cellular adhesion molecules in HIV type 1 infection and their impact on virus neutralization. AIDS Res Hum Retroviruses 1999;15:523-31.
22. Poignard P, Saphire E, WHI Parren P, et al. GP120: biologic aspects of structural features. Ann Rev Immunol 2001;19:253-74.
23. Kwong P, Wyatt R, Sattentau Q, et al. Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus. J Virol 2000;74:1961-72.
24. Shu W, Ji H, Lu M. Trimerization specificity in HIV-1 gp41: analysis with a GCN4 leucine zipper model. Biochem 1999;38:5378-85.
25. Kwong P, Wyatt R, Robinson J, et al. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 1998;393:648-59.
26. Kim M, Chen B, Hussey R, et al. The stoichiometry of trimeric SIV glycoprotein interaction with CD4 differs from that of anti-envelope antibody Fab fragments. J Biol Chem 2001;276:42667-76.
27. Kuhmann S, Platt E. Kozak S, et al. Cooperation of multiple CCR5 coreceptors is required for infection by human immunodeficiency virus type 1. J Virol 2000;74:7005-15.
28. Zhu P, Chertova E, Bess J, et al. Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions. Proc Natl Acad Sci USA 2003;100:15812-7.
29. Turner B, Summers M. Structural biology of HIV. J Vol Biol 1999;285:1-32.
30. Chan D, Pass D, Berger J, et al. Core structure of gp41 from the HIV envelope glycoprotein. Cell 1997;89:263-73.
31. Center R, Leapman R, Lebowitz J, et al. Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface. J Virol 2002:76:7863-7.
32. Popik W, Alce T, Au W. Human immunodeficiency virus type 1 uses lipid raft-co-localized CD4 and chemokine receptors for productive entry into CD4(+) T-cells. J Virol 2002:76:4709-22.
33. Singer I, Scott S, Kawka D, et al. CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T-cells. J Virol 2001;75:3779-90.
34. Xiao X, Wu L, Stantchev T, et al. Constitutive cell surface association between CD4 and CCR5. Proc Natl Acad Scl USA 1999;96:7496-501.
35. Trkola A, Dragic T, Arthos J, et al. CD4-dependent, antibody-sensitive interactions between HIV-1 and its coreceptor CCR-5. Nature 1996;384:184-7.
36. Wang L, Chen J, Gelman B, et al. How does HIV cause depletion of CD4 lymphocytes? A mechanism involving virus signaling through its cellular receptors. Curr Mol Med 2001;1:545-50.
37. Gunaratnam M, Grant M. Damage to F-actin and cell death induced by chromium VI and nickel in primary monolayer cultures of rat helpatocytes. Toxicol In Vitro 2004;18:245-53.
38. Carbonell G Falcon R, Yamada A, et al. Morphological and intracellular alterations induced by Serratia marcescens cytotoxin. Res Microbiol 2004;155:25-30.
39. Domnina L, Ivanova O, Pletjushkina O, et al. Marginal blebbing during the early stages of TNF-induced apoptosis indicates alteration in actomyosin contractility. Cell Biol Int 2004;28:471-5.
40. Bohm I. Disruption of the cytoskeleton after apoptosis induction with auto-antibodies. Autoimmunity 2003;36:183-9.
41. Harada T, Tatsuml M, Takahashi H, f. Specific reactions between purified HIV-1 particles and CD4+ cell membrane fragments in a cell-free system of virus fusion or entry. Microbes Infect 2004;6:421-8.